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Pneumonia  virus  of mice  (PVM)  was first  isolated  as  a  latent  agent  from 
apparently healthy mice (1,  2),  and pulmonary disease  was produced only by 
intranasal  inoculation of lung material  and serial  blind passage.  Evidence of a 
high  incidence  of inapparent  PVM  infection has  been found in  a  number  of 
laboratory mouse colonies from a  variety of sources (2-4), and antibodies have 
also been detected in other mammalian species (3, 5). 
The virus is highly thermolabile  (2,  6),  ether sensitive  (7),  and combines with a 
lung tissue component from a  variety of mammalian species  (8).  PVM agglutinates 
mouse and  hamster  erythrocytes  (9,  10),  but  unless  special  precautions  are  taken 
when harvesting infected lungs  (11),  combination of the virus with the tissue com- 
ponent occurs, and hemagglutination can be detected only after the virus is freed by 
treatment such as heating to 70°C  (9). 
The  multiplication  of PVM  in  the  mouse  lung  is  inhibited  by polysaccharides 
obtained from several bacteria (12), and the first example of successful  chemotherapy 
of a  virus  infection  in  an  animal  was  reported  in  1951 by  Ginsberg  and  Horsfall 
(13)  who used  the capsular polysaccharide of Friedl~nder  bacillus  type B  in mice 
infected with PVM. 
PVM has been propagated in minced chick embryo cultures  (1,  2)  and grown to 
low titer in primary cultures of suckling hamster kidney cells (14),  but little is known 
about the replication, structure,  or chemistry of the virus. 
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The present communication describes the multiplication of PVM  in a  line of 
baby  hamster  kidney  (BHK21)  cells,  and  the  cytological  changes  induced  in 
these  cells  as  shown  by  cytochemical  and  immunofluorescent  staining.  The 
paper  which  follows  describes  electron  nficroscopic  studies  of  the  virus  and 
virus-infected cells (15).  Evidence  will be presented suggesting that PVM  is an 
RNA  virus that  replicates in  the cytoplasm  and resembles the  myxoviruses in 
structure  and replication. 
Materials  and Methods 
Cell Cultures.--The  BHK21 baby hamster kidney cell line (16) was obtained in its 56th 
passage from Dr. N. Karahatsos of The Rockefeller Foundation Virus Laboratory, who had 
obtained it in its 45th passage from Dr. M. Stoker. The cells were grown in a modified Eagle's 
medium with 10% unheated calf serum and  10% tryptose phosphate broth. The BHK21-F 
cell line (17) is a heteroploid variant of the BHK21 line, and is highly susceptible to fusion by 
the simian parainfluenza virus SV5 (17) and by visna virus (18). The HKCC cell line is a con- 
tinuous line of adult Syrian hamster kidney cells which were obtained from Dr. C. It. Calisher 
of Microbiological Associates,  Inc. BHK21-F and HKCC cells were propagated in reinforced 
Eagle's medium (19) with 10% calf serum and 10% tryptose phosphate broth. 
Virus.--PVM was propagated in 3-wk old Rockefeller University Swiss mice by intranasal 
inoculation of infected mouse lung suspension containing 104.* MSs0 (50% maximum score)  of 
virus. 4 days after inoculation, surviving animals were sacrificed,  and the lungs were removed 
under sterile conditions and homogenized. A 20% lung suspension was prepared  in Eagle's 
minimum essential medium (20) with 1% bovine plasma albumin (BSA)  (Fraction V, Armour 
Pharmaceutical Co., Kankakee, Ill.) and stored at -60°C until used. 
PVM was also propagated  in baby hamster kidney cells by the inoculation of confluent 
monolayers (approximately 6 X  106.o cells) in 60-ram plastic Petri dishes with 0.5 ml of undi- 
luted virus suspension from either mouse lung or previous tissue culture passage. After adsorp- 
tion for 3 hr at 37°C, the cultures were incubated in a modified Eagle's medium (21) with 10% 
calf serum at 37°C in humidified 5% CO2 in air. At harvest, BSA was added to a concentration 
of 0.5%, and the supernatant medium was collected and stored at -60°C. 
Immune Sera.--Antisera  to PVM grown in the mouse lung and in BHK21 cells were pre- 
pared by injecting adult rabbits intravenously with 10 ml of virus suspension containing ap- 
proximately 1280 hemagglutinating (HA) units, followed in 9 days by the intraperitoneal ad- 
ministration of 640 HA units. The rabbits were bled 9 days later, and sara were heated at 56°C 
for 30 rain before use. 
Assay of Infective  Virus in Cell Culture.--Tenfold  dilutions of virus were prepared in rein- 
forced Eagle's medium with 0.5% BSA, and held in an ice bath until inoculation. Confluent 
monolayers of BHK21 cells in 60-ram plastic Petri dishes were washed twice with phosphate- 
buffered saline (PB S), pH 7.2 (22), and inoculated with 0.5 ml of virus, six monolayers per dilu- 
tion. After 3 hr at 37°C,  5.0 ml of modified Eagle's medium with 1% inactivated calf serum 
was added and the cultures were incubated at 37°C for 10 or I1 days. Medium from each plate 
was then harvested and tested for hemagglutinin. 50% infectivity end points (TCID~0) were 
calculated by the method of Reed and Muench (23). 
Infectivity litrations in the mouse were performed as described by Horsfail and Curnen (6), 
except that virus dilutions were prepared in reinforced Eagle's medium with 0.5% BSA. The 
results of animal titrations were expressed as 50% mortality (LDs0) or 50% MSs0 endpoints 
based on the extent of pulmonary consolidation (24). 
ltemagglutination  and  hemagglutination-inhlbition  titrallons  were performed as previously 
described (25) using a 0.8% suspension of freshly prepared mouse erythroeytes in PBS with 
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Neuramlnidase from V. cholerae, 500 units/ml, was obtained from Calbiochem, Los Angeles, 
Calif. A unit is defined as that amount of enzyme which splits 1 pg of N-acetylneuraminic 
acid from a glycoprotein substrate obtained from human serum (fraction I, Dische) in 15 rain 
at 37°C. 
Staining Proeedures.--BHK21 cells were grown to confluent monolayers in plastic Petri 
dishes containing 18-ram  square glass cover slips and inoculated with tissue culture---grown 
PVM  at  a  multiplicity of a  0.5  TCIDs0  per cell; controls were inoculated with  medium. 
Modified Eagle's medium with 10% inactivated calf serum was added  after an adsorption 
period of 3 hr, and the cultures were incubated at 37°C. At 24, 48, 72, and 96 hr after inocu- 
lation, replicate cover slips were harvested; one set of cover slips was fixed in Zenker's fluid 
for 60 min and stained with hematoxylin and eosin (26);  a second set was fixed in Carnoy's 
fixative and  stained  with 0.05%  acridine orange  stain  (27);  a  third  set was washed  with 
PBS, fixed in acetone, and stained by the indirect fluorescent antibody technique (28).  The 
PVM rabbit antiserum, normal rabbit serum, and goat anti-rabbit globulin conjugated with 
TABLE I 
Multiplication of PVM in Hamster Kidney Cell Lines 
Virus yield, hemagglutinating units/ml 
Time  Cells 
BHK21  BHK21-F  HKCC 
days 
3 
5 
7 
10 
12 
4 
512 
1024 
4096 
8192 
<4 
<4 
128 
1024 
8192 
<4 
<4 
<4 
32 
32 
fluorescein isothiocyanate (Microbiological Associates, Inc., Bethesda, Md.)  used in fluores- 
cent antibody  studies  were absorbed  with acetone-extracted guinea pig liver powder  and 
BHK21 cell powder. Fluorescent antibody and acridine orange--stained cells were examined 
and photographed with a Zelss Ultraphot II photomicroscope using an Osram 200 watt high 
pressure mercury lamp, a  BG12 exciter filter, and  an OG4 barrier filter. 
RESULTS 
Multiplication of PVM  in Hamster Kidney Cells 
To determine whether PVM would multiply in BHK21, BHK21-F, or HKCC cells,  rep- 
licate monolayers in 60-ram Petri dishes, containing 6-10 X  106 cells, were inoculated with 
8 X  104 MS~0 of virus grown in mouse lung, and incubated at 37°C. At intervals, the medium 
was removed and assayed for PVM hemagglutinin, and fresh medium was added. 
The  results  shown  in Table  I  indicate  that  virus  replication  occurred  in all 
three  cell types,  although  the  yield from  HKCC  cells was  very low.  Hemag- 
glutinin  was  produced  most  rapidly  and  in  largest  amount  by  BHK21  cells; 
therefore,  this cell line was chosen for use in subsequent  experiments. 254  REPLICATION  OF  PVM  IN  CELL  CULTURE 
Serial Passage of PVM in BHK21 calls.- 
12 serial passages of PVM were made in BHK21 cells, inoculating in each ease undiluted 
virus-containing medium from the preceding passage. Virus was harvested  at 4 or 5 days 
after inoculation. 
The yield of infective PVM in the first passage was 1.0 X  10  s'° TCIDso per 
rnl, and in the last  passage, 6.3  X  10s'°; the  hemagglutination  titers  were 512 
and 1024, respectively, and there was little variation in yield in the intervening 
passages. The TCIDso per HA ratios ranged from 108.8 to 1@ .1,  with a mean of 
108.~. The moderate differences in the TCID~0 per HA ratios  of these passages 
probably  reflect  the  thermal  lability  of this  virus,  as  well  as its  mechanical 
fragility, as will be discussed below. 
A number of experiments were carried out in BHK21 cells using various media 
and  incubation  at temperatures  varying from 33°C  to 37°C,  and it  was con- 
cluded  that  the  highest virus  yields were obtained by incubation  at 37°C  in 
modified Eagle's medium with  10 %  calf serum which had been inactivated  at 
56°C for 30 min. 
These  results  in  BHK21  cells  are  in  contrast  with  those  of  Tennant  and 
Ward (14) who found, in primary cultures of suckling  hamster kidney, a maxi- 
mum titer  of 103 "~ TCID~0 on the first passage  and  a  decrease by the  eighth 
passage to only 101.8 TCIDs0. 
Adsorption  of PVM to  BHK21 Cells.- 
Since a plaque assay of PVM is not yet available, determination  of the rate of adsorption 
of infective virus BHK21 cells was not attempted,  but the adsorption of hemagglutinin was 
studied using the precise fractional hemagglutination titration  method of HorsfaU and Tamm 
(29). Replicate monolayers of BHK21 cells were washed three times, inoculated  with 0.5 ml 
containing 256 hemagglutinating units of virus, and incubated  at 37°C; at 30-rain intervals 
the inoculum was removed and assayed for uuadsorbed hemagglntinin. The geometric means 
of two determinations were taken for each time point. 
As shown in Text-fig. 1, 3 hr were required for 80 % adsorption to occur, and 
this time was selected as the adsorption period in subsequent experiments. 
Kinetics  of PVM replication in BHK21 cells.--The amount of infective virus 
obtained from BHK21 cells is not sufficient to permit inoculation of cells at a 
high enough virus/cell multiplicity to give a  single cycle growth curve,  and it 
has not been possible to concentrate this labile virus without loss of infectivity. 
However,  virus  stocks  were  obtained  with  an  infectivity  titer  sufficient  to 
inoculate at a multiplicity of 0.5 TCIDs0 per cell,  and this was done in all the 
following experiments on PVM replication. 
Replicate  monolayers  were washed  twice with  PBS  and  inoculated  with  virus.  After 
adsorption  for 3 hr at 37°C, the inoculum was removed, the cells were washed twice with 
PBS; modified Eagle's  medium with  the  10% calf serum was added,  and the dishes were 
incubated at 37°C. At intervals, cells from two dishes were scraped from the plastic surface, DONALD  H.  HARTER  AND  PURNELL  W.  CHOPPIN  255 
cells and supernatant  medium  were harvested,  and  BSA was added  to a  concentration  of 
0.5%.  Samples were  rapidly frozen and  thawed three times, and centrifuged at  1500 g  for 
10 rain at 4°C to sediment debris. The supernatant was stored at  --00°C until assayed for 
infectivity and hemagglutinin. 
The results of such an experiment are shown in Text-fig. 2. The maximum 
titer of infective PVM was obtained at 72 hr, and there was a decline after 96 
hr. The peak titer in this experiment of 4  X  106 TCID,0 per ml represents a 
yield of approximately 4 TCIDs0 per cell; however,  this must be  taken as a 
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Tzxx-~G. 1.  Adsorption of PVM hemagglutinin to BHK21 cell monolayers at 37°C. 
minimum yield because of the extreme thermal lability of the virus. Text-fig. 2 
also shows that the yield of PVM hemagglutinin continued to rise after the 
titer of infective virus had begun to decline, reflecting the previously known fact 
that hemagglutinating activity is a much more stable property than infectivity. 
Effect of Halogenated Deoxyuridines on PVM Replication.--To investigate the 
type of nucleic acid in the PVM virion, the effect of 5-fluoro-2'-deoxyuridine 
(FUDR),  5-bromo-2'-deoxyuridine  (BUDR),  and  5-iodo-2'-deoxyuridine 
(IUDR)  on the replication of the virus was determined. Each of these com- 
pounds inhibits the synthesis of DNA viruses (30-33). 
Replicate monolayers of BHK21 cells were inoculated with PVM at a multiplicity of 0.5 
TCID6c per cell, and the yield of virus after incubation for 4 days at 37°C with each of the 256  REPLICATION  OF  PVM  IN  CELL  CULTURE 
halogenated deoxyuridines present in the medium was determined. Vacciula, a DNA virus, 
was included as a control in each experiment. 
As shown in Table II, there was no significant inhibition of the replication of 
either infective virus or hemagglutinin  by any of the  compounds,  suggesting 
that PVM is an RNA virus. 
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Tzxr-l~o. 2.  Growth of PVM in BHK21 cells at 37°C. Monolayers were inoculated at a 
multiplicity of 0.5 TCIDs0  per cell. 
Cytopathic Changes in PVM-Infected Cells.--In  BHK21 cells inoculated at a 
multiplicity of 0.5  TCIDs0 per  ml,  cytopathic  effects consisting  of scattered 
rounding  of cells followed by detachment from the surface, began to  appear 
around 48 hr after infection. Although rounded cells and areas devoid of cells 
were apparent after this time, much of the cell monolayer was still intact after 
96 hr. At about 48 hr after infection, eosinophilic cytoplasmic inclusions were 
detected in hematoxylin- and eosin-stained preparations, and these inclusions 
became large and numerous by 72-96 hr (Fig.  1). 
Acridine orange stains double-stranded DNA and RNA orthochromatically 
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the staining conditions employed in the present experiments (34-37).  PVM- 
infected  BHK21  ceils  stained  with acridine orange 48 hr or  more after in- 
fection showed accumulations of intensely stained, bright red  material in the 
cytoplasm, which in size, shape,  and distribution corresponded to eosinophilic 
cytoplasmic inclusions described above. There was no evidence of virus-induced 
nucleic acid in the nuclei of infected cells. 
Fluorescent antibody-stained  infected  BHK21  cells  showed  viral  antigen 
localized in the cytoplasm. Antigen was first detected at 24 hr; clusters of cells 
containing antigen were surrounded by cells without specific  fluorescence,  re- 
flecting the multiple cycles of infection under the conditions employed. Maxi- 
mum staining was seen at 72 hr (Fig. 2).  No evidence of viral antigen in the 
nuclei was detected. 
TABLE II 
Lack of Effe,  t of Halogenated Deoxyuridines on the Multipllcation of PVM in BHK21 Cells 
Compound 
None 
BUDR, 10  4  M 
FUDR, 10  -6 M 
IUDR, 10  -5 M 
Virus yield* 
Infective virus, TCIDio/ml 
5.6  )<  106 
4.5  X  106 
2.9  )<  10  e 
3.9 X  106 
Hemagglutinating units/ml 
182 
182 
128 
182 
In parallel experiments each compound caused  >96% inhibition of vaccinia virus multi- 
plication. 
* Harvested at 4 days. Means of two experiments. 
The results of these studies with acridine orange, fluorescein-labeled antibody, 
and  halogenated  deoxyuridines,  suggest  that  PVM  is  an  RNA  virus  that 
replicates in the cytoplasm; and that the RNA is a single-stranded molecule. 
Properties of PVM Grown in BHK21 Calls 
Hemagglutination by PVM Grown in BHK21 Cells.--To investigate whether 
PVM grown in cell culture is combined with a tissue component which inhibits 
hemagglutination, as is the case with PVM in mouse lung suspension, the effect 
of heat on virus grown in cells and in the mouse lung was determined. Both 
released virus, found in the supernatant medium of cultured BHK21 cells, and 
cell-associated  virus,  obtained  after  harvesting  the  cells  and  freezing  and 
thawing three times, were  employed. 
As  shown in Table III,  the  hemagglutinating activity of PVM  grown in 
BHK21 cells did not increase after heating, in contrast to that of virus from 
the mouse lung.  That PV-M produced by BHK21  cells  can combine with  a 258  REPLICATION  OF PVM  IN CELL  CULTURE 
component of mouse lung was demonstrated by  mixing the virus with mouse 
lung  homogenate  and  assaying for hemagglutinin  (Table  IV).  These  results 
indicate that PVM grown in cell culture is not combined with a cellular inhibitor 
that prevents hemagglutination,  and thus is similar to the free virus Curnen 
and Horsfall obtained by carefully perfusing the infected mouse lung (11,  38). 
Incubation  of  a  0.8%  suspension  of  murine  erythrocytes with  8  units  of 
neuraminidase  did not prevent agglutination by 8 hemagglutinating units  of 
PVM grown in BHK21 cells, whereas I unit of enzyme prevented agglutination 
TABLE III 
Effect of Heat on Hemagglutination by PVM Grown in Mouse Lung and in BHK21 Cells 
Source of virus 
Mouse lung 
BHK21 cells, released virus* 
BHK21 cells, cell-associated  virus~/ 
Hemagglutination tater 
Unheard  70°C,  30  mm 
<8  512 
1024  512 
512  512 
* In supernatant medium. 
5~ Obtained after freezing and thawing cells 3 times. 
TABLE IV 
Inhibition by Mouse Lung Homogenate of Hemagglutination by PVM Grown in BHK21 Cdls 
HemagglutinatAon titer 
Treatment of virus* 
Unheated  70°C, 30 min 
PVM +  medium  512  256 
PVM +  mouse lung homogenate  <4  256 
* Virus was mixed with equal volumes of reinforced Eagle's medium with 0.5% BSA or a 
10% (w/v) suspension of mouse lung homogenate, held at 37°C for 30 min, centrifuged at 
1500 g, and the supematant titered. 
of such  erythrocytes by 8  units  of the Lee strain of influenza B  virus.  This 
suggests that  a  neuraminic  acid-containing  receptor is not required  for virus 
adsorption; however, the possibility cannot be excluded that the virus adsorbs 
to a receptor that contains neuraminic acid residues in linkages that are either 
insusceptible  or inaccessible to the neuraminidase  used  in  these experiments. 
Antigenic Similarity of PVM  Grown in BttK21 Cdls and the Mouse Lung.-- 
In early experiments it was found that a  1:2048 dilution of antiserum against 
PVM grown in the mouse lung neutralized  3000 TCIDu0 of virus  which  had 
undergone 7 passages in BHK21 cells. To investigate whether serial passage in 
cell culture  had resulted  in any demonstrable antigenic changes in  the virus, DONALD H.  HARTER AND  PURNELL W.  CHOPPIN  259 
PVM  from the  10th  passage in BHK21  cells and from the mouse lung were 
compared  in  cross  hemagglutination-inhibition  titrations  with  their  corre- 
sponding rabbit antisera. As shown in Table V, no significant antigenic differ- 
ences were detected. 
Virulence in Mice of PVM  Grown in BHK21  CeUs.--The ability of PVM, 
which had undergone 10 passages in cell culture, to cause pulmonary consolida- 
TABLE V 
Antigenic Similarity  of PVM Grown in Mouse Lung and BHK21 Cells 
Rsbbit antiserum  against virus grown in 
Hemaggintinstion-inhibition  titer* 
Virus grown in 
Mouse lung  BHK21 cells 
Mouse  3620  3620 
BHK21 cells  5120  7240 
* Geometric means of two experiments. 
TABLE  VI 
Comparison of the Infectivity in Cell Culture and in Mice of PVM Grown 
in Mouse Lung and in BHK21 Cells 
Source of virus 
Infectivity  tlter* 
In BHK21 cells  In mice 
TCID~  MSH  LDN 
Mouse lung  6.5 X  l0  s  6.4 X  105  1.8 X  10  s 
BHK21  cells~  6.3 X  l0  s  1.5 X  I04  5.0 X  I0  a 
* Per  gram of  mouse  lung  or  per  milliliter  of  virus-containing  medium. 
10th passage virus. 
tion and death in mice was investigated by comparing virus grown in BHK21 
cells with virus from the mouse lung with respect to LD~0 and MS~o titers in 
mice, and infectivity titers  (TCID60) in BHK21 cells.  As shown in Table VI, 
the TCIDso and MSs0 titers of virus grown in the mouse lung were similar, in- 
dicating that BHK21 cells are as sensitive an indicator of PVM from the mouse 
lung as is the mouse itself. On the other hand, the virus grown in BHK21 cells 
had an MS~0 titer over 100-fold lower than the TCID~o titer, and also a lower 
LD~o titer. Thus, after 10 passages in cell  culture,  the virus appears to be less 
virulent, though still capable of inducing pulmonary disease and death if given 
in sufficient amounts. 260  REPLICATION  OF PVM  IN CELL CULTURE 
Attempts to Concentrate and Purify PVM.-- 
In attempts to obtain concentrated virus suspensions for single cycle multiplication  experi- 
ments and for study of the properties of the virion, PVM was subjected  to centrifugation in 
various gravitational fields and to ammonium sulfate precipitation.  Results of representative 
experiments are shown in Table VII. 
In  repeated  experiments,  centrifugation  resulted  in  very  poor  recovery  of 
infectivity. Initial experiments were done at 79,000 g because of the previously 
reported size of 40 m~ (11); however, after it was found by electron microscopy 
that the virus particle is 80-120 m~ in diameter (15), sedimentation at 20,000 g 
was  also  carried  out  without  successful  recovery  of  infectivity.  Ammonium 
sulfate precipitation also failed to give a satisfactory recovery of infective virus. 
TABLE VII 
Loss  of Infectivity  and Increase in Hemagglutinating Activity  of PVM after Contrifugation 
or Ammonium Sulfate Precipitation 
Procedure 
20,000 g, 180 min 
64,000 g, 180 rain 
79,000 g, 180 vain 
Ammonium sulfate 
PVM recovered 
Infective  virus 
% 
13 
26 
4 
7 
Hemagglutlnating  units 
% 
210 
820 
228 
430 
Although  recovery of infectivity was very low, greater than  100 %  recovery 
of hemagglutinin  was consistently  obtained,  a  result  which  suggests  that  the 
labile virus particles may have fragmented  during  the procedure,  resulting  in 
a loss of infectivity but an increase in the number of particles capable of hem- 
agglutination.  A  loss of infectivity  accompanied by an increase in hemagglu- 
tination  titer is known  to occur after disruption of influenza virus particles by 
ether (39-41). 
Density  Gradient Centrifugation.--PVM  was subjected  to equilibrium  zonal 
centrifugation in potassium tartrate in an attempt to purify the virus and deter- 
mine its buoyant density. 
A virus suspension was used which had an infectivity titer of 3.2 X  10. TCID~o per ml, 
a  hemagglutination  titer  of  1024, and  a  TCIDs0/I-IA  ratio  of  10  *.5. Virus,  0.4  ml,  was 
layered onto a preformed continuous  5-50%  (w/w)  gradient of potassium tartrate in 0.1 
phosphate buffer, pH 7.0, containing  0.001 ~  EDTA, and centrifuged  at 100,000 g for 3 hr 
in a  Spinco SW39L rotor. Three drop fractions were collected from below and assayed for 
infectivity and hemagglutinin. 
Text-fig. 3 shows the results of a  typical experiment in which approximately 
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found in two peaks, with the major portion in a single fraction with a  density 
of approximately 1.15,  and a  smaller amount  at a  density of  approximately 
1.23.  The hemagglutination  titers  of the fractions which  contained the  two 
peaks of infectivity were low,  i.e.  5  units per ml.  The TCIDs0/HA  ratio  of 
the lighter, major peak of infectivity was 104"s, and that of the heavier, smaller 
peak 10  ~.3. Although most of the infectivity was in the lighter peak, there was 
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TExT-I~6. 3. Equilibrium zonal centrifugation of PVM in potassium tartrate.  Virus sus- 
pension was placed on a preformed  gradient and centrifuged  at 100,000  g for 3 hr at 4°C. 
no  visible band  in  the gradient at  that point; however, the  relatively small 
amount of infective virus in the heavier peak was associated with a  distinct 
band of flaky opalescent material, suggesting that the lighter fraction with a 
density of 1.15 contained infective virus sedimenting as such, while the heavier 
band consisted of virus adsorbed to or combined with, some cellular component 
which was responsible for the visible material. 
In contrast to the distribution of infective virus, most of the hemagglutinating 
activity was found in a sharp peak at a density of 1.13, and there was very little 
associated  infectivity. The TCIDs0  per  HA  ratio of the  fraction with  peak 262  REPLICATION  OF  PVM  IN  CELL  CULTLrRE 
hemagglutinating activity was only 101. Thus, most of the hemagglutinating 
acitivity was associated with noninfective particles, which probably represented 
fragments of the envelope of this labile virus, or virus particles which had lost 
their nucleoprotein internal component. As shown in the accompanying paper 
(15), PVM is structurally similar to the myxoviruses, and hemagglutination by 
noninfective fragments of these viruses is well established. 
DISCUSSION 
Although PVM has been studied extensively in the mouse,  a  suitable cell 
culture was not previously available, and thus knowledge of the nature of the 
virus and its multiplication has been limited. The ability to propagate PVM in 
BHK21 cells has provided the means of studying the virus at the cellular level, 
and significant information has been gained regarding the physical and chemical 
properties of the virus, and its site of replication and mode of assembly. The 
availability of a cell culture system should also facilitate an investigation of the 
mechanism of the inhibitionof PVM multiplicationby bacterial polysaccharides. 
The lack of effect of halogenated deoxyuridines on PVM replication indicates 
that it is an RNA virus,  and the metachromatic, red staining with acridine 
orange suggests that the viral RNA is single-stranded. Both the cytochemical 
and immunofluorescence studies have produced evidence that the virus replicates 
in the cytoplasm, a conclusion which is also supported by the electron micro- 
scopic studies reported in the following communication (15).  A comparison of 
the  hematoxylin-eosin- and  acridine  orange-stained  preparations  of  PVM- 
infected cells  suggests that the eosinophilic cytoplasmic inclusions present in 
such cells contain RNA; and electron microscopic observations are compatible 
with the conclusion that these inclusions represent collections of viral internal 
component or nucleocapsid (15).  Although all the available data indicate that 
PVM replicates only in the cytoplasm, the possibility cannot  be  completely 
excluded that a transient nuclear phase in the synthesis of some viral component 
or precursor occurs but has not been detected. 
Curnen and coworkers (11) in studies of the sedimentation velocity of PVM 
hemagglutinin in sucrose solutions concluded that the hemagglutinating parti- 
cle was 40 mu in diameter and had a density of 1.13 g/ml. However, they were 
unable to assay the virus by infectivity after centrifugation, and emphasized 
that the 40 m~ size was a  minimum estimate which represented the smallest 
hemagglutinating particles present in appreciable quantity. Our electron micro- 
scope studies (15)  indicate that PVM particles, many of which are long fila- 
ments, are 80-120 mp in diameter and possess  an envelope covered with pro- 
jections. The envelope is acquired at the cell surface where the virus particle 
matures by a process of budding from the cell membrane. Thus PVM is struc- 
turally similar to the myxoviruses. It is easily disrupted by centrifugation or 
precipitation, which results in a loss of infectivity and an increase in hemagglu- DONALD  H.  HARTER  AND  PURNELL  W. CHOPPIN  263 
tinating activity. It is known that disruption of myxoviruses yields fragments 
which hemagglutinate (39-41),  and fragmented or disrupted PVM  particles 
provide an explanation for the 40 n~u hemagglutinin described by Curnen and 
coworkers (11).  This interpretation is supported by the present finding that 
infective virus has a density in potassium tartrate of 1.15, whereas noninfective 
hemagglutinin has a density of 1.13, which is identical to that reported for the 
40 m~ hemagglutinin by the above authors. 
The  separation in  a  gradient of lighter,  noninfective hemagglutinin from 
infective virus appears to reflect extreme fragility of PVM. The thermal lability 
of this virus was demonstrated very early (2, 6) and its fragile nature has been 
manifest in the present studies in the inability to concentrate it by usual means, 
and in  the disruption of unfixed virus during negative staining for electron 
microscopy (15).  The finding that  stock virus preparations had  an  average 
TCIDs0/HA ratio of 103"7, whereas infective virus, separated from noninfec- 
tive hemagglutinin by gradient centrifugation, had a  ratio of 104's, indicates 
that there is much noninfective hemagglutinin in virus stocks. 
SUMMARY 
Pneumonia virus of mice (PVM) has been serially propagated in a  line of 
baby hamster kidney (BHK21) cells. A maximum titer of 6.3 X  10  e TCID~0 per 
ml was obtained, and there was little variation in yield on serial passage. 
PVM grown in BHK21 cells was antigenically similar to virus obtained from 
the mouse lung, but was somewhat less virulent for the mouse after 10 serial 
passages in these cells.  Virus produced by BHK21  cells  agglutinated mouse 
erythrocytes without prior heating or other treatment. 
Sedimentation of PVM in the ultracentrifuge or precipitation by ammonium 
sulfate resulted in  a  loss  in infectivity but  an increase  in hemagglutinating 
activity, presumably due to disruption of the virus particle.  In a  potassium 
tartrate density gradient, the major portion of infective virus sedimented at a 
density of approximately 1.15, and noninfective hemagglutinin, at a  density 
of approximately  1.13. Stock  virus  preparations  appear  to  contain a  large 
amount of noninfective hemagglutinin. 
The  replication of PVM was not inhibited by 5-fluoro-2'-deoxyuridine, 5- 
bromo-2'-deoxyuridine,  or  5-iodo-2'-deoxyuridine.  Infected  cells  contained 
eosinophilic cytoplasmic inclusions which showed the acridine orange staining 
characteristic of single-stranded RNA. Foci of viral antigen were observed in 
the cytoplasm of infected cells by fluorescent antibody staining. 
The results suggest that PVM is an RNA virus that replicates in the cyto- 
plasm. 
The  authors wish  to  thank  Mrs.  Karen  Funk  and  Mr.  Salvatore  Spatola  for excellent 
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EXPLANATION OF PLATE 19 
FIG.  I.  Eosinophilic intmcytoplasmic inclusions  (arrows)  in  BHK21  cells  72  hr 
after infection with PVM at a multiplicity of 0.5 TCIDs0 per cell. Hematoxylin and 
eosin stain.  X 460. 
FIG. 2. PVM antigen in the cytoplasm of BHK21 cells  72 hr after infection with 
PVM at a multiplicity of 0.5 TCIDs0 per cell. Stained  by the indirect immunofluo- 
rescence technique.  X  580. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 126  PLATE  19 
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